1 active not recruiting, 1 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Non-obstructive Hypertrophic Cardiomyopathy: new trials by email Literature Review of Non-obstructive Hypertrophic Cardiomyopathy trials Research Report on Non-obstructive Hypertrophic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy Sotagliflozin, Placebo - Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy | Phase 3 | Active not recruiting | Lexicon Pharmaceuticals | 500 | 2024-09-24 | 2026-08-26 |
| A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM mavacamten - Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | Completed | Bristol-Myers Squibb | 314 | 2018-09-27 | 2026-02-20 |
Cardiomyopathy, Hypertrophic (2)
Aortic Stenosis, Subvalvular (2) · Aortic Valve Disease (2) · Aortic Valve Stenosis (2) · Cardiomyopathies (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Valve Diseases (2)
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol (1) · MYK-461 (1)
Bristol-Myers Squibb (1) · Lexicon Pharmaceuticals (1)
Belgium (2) · Czechia (2) · France (2) · Germany (2) · Israel (2) · Italy (2) · Poland (2) · Portugal (2) · United Kingdom (2) · United States (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · Croatia (1) · Denmark (1)